1-3 of 3
Hideki Mitsui
Close
Sort by
Journal Articles

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Kenji Nozaki, MD, Hiroyuki Sugahara, MD PhD, Shuji Ueda, MD PhD, Jun Ishikawa, MD PhD, Shigeo Fuji, MD PhD, Hiroaki Masaie, MD PhD, Yuma Tada, MD, Makiko Suga, MD, Kazuhito Tsutsumi, MD, Kumi Shibata, MD, Shuhei Kida, MD, Takahiro Karasuno, MD PhD, Hiroshi Sata, MD PhD, Masato Yasumi, MD PhD, Masato Iida, MD PhD, Hideki Mitsui, MD PhD, Tsuyoshi Kamae, MD PhD, Norimitsu Saito, MD PhD, Hiraku Murakami, MD, Yasuhiro Moriyama, MD PhD, Manabu Kawakami, MD PhD, Ruri Kato, MD PhD, Yoshiki Nakae, MD PhD, Toru Kida, MD, Satoru Kosugi, MD PhD, Hirohiko Shibayama, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3985.
https://doi.org/10.1182/blood-2019-126399
Published: 2019
Journal Articles

Clinical Meanings of Quantitative PCR of Patient-Specific Immunoglobulin VDJ Regions Using Various Materials of Myeloma Patients

Hiroshi Sata, Hirohiko Shibayama, Ikuhiro Maeda, Yoko Habuchi, Eiji Nakatani, Kentaro Fukushima, Jiro Fujita, Sachiko Ezoe, Seiji Tadokoro, Tetsuo Maeda, Masao Mizuki, Satoru Kosugi, Masashi Nakagawa, Shuji Ueda, Masato Iida, Yukihiro Tokumine, Hideki Mitsui, Yasuhiko Azenishi, Kenji Oritani, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2049.
https://doi.org/10.1182/blood.V124.21.2049.2049
Published: 2014
Journal Articles

Growth-Supporting Activities of Fibronectin on Hematopoietic Stem/Progenitor Cells In Vitro and In Vivo: Structural Requirement for Fibronectin Activities of CS1 and Cell-Binding Domains

Takafumi Yokota, Kenji Oritani, Hideki Mitsui, Keisuke Aoyama, Jun Ishikawa, Hiroyuki Sugahara, Itaru Matsumura, Schickwann Tsai, Yoshiaki Tomiyama, Yuzuru Kanakura, Yuji Matsuzawa
Journal: Blood
Blood (1998) 91 (9): 3263–3272.
https://doi.org/10.1182/blood.V91.9.3263
Published: 1998